The CDC article maintained that reviews of randomised trials that are controlled maybe not fully notify issue of whether antiviral therapy reduces serious problems of influenza.
It is additionally maintained that “reviews of RCTs . . . have discovered consistent medical good thing about very early oseltamivir therapy in decreasing the threat of lower respiratory system complications.”
Neither Jefferson nor Doshi ended up being impressed utilizing the CDC’s reaction, that they challenged in five follow-up e-mails.
Jefferson told the BMJ a week ago that the US Food and Drug management had described Tamiflu’s impacts as modest. “Despite this, whom and CDC have already been extensively advertising the medication. Who has got made Tamiflu one of several crucial drugs, therefore it sits door that is next aspirin and penicillin, cortisone,” he said.
“The CDC has extensively suggested the utilization of Tamiflu, and, on the advice, essentially, of WHO as you know, governments worldwide have stockpiled it.
Leer másTamiflu: the battle for key drug data. Influenza medication oseltamivir has made billions
